Product Monograph - Ask Novartis Pharma
... Diclofenac is associated with an increased risk of cardiovascular adverse events (such as myocardial infarction, stroke or thrombotic events, which can be fatal) that is comparable to COX-2 inhibitors. Meta-analyses of randomized clinical trials comparing several different NSAIDs suggest that diclof ...
... Diclofenac is associated with an increased risk of cardiovascular adverse events (such as myocardial infarction, stroke or thrombotic events, which can be fatal) that is comparable to COX-2 inhibitors. Meta-analyses of randomized clinical trials comparing several different NSAIDs suggest that diclof ...
... time of the day (i.e. 7:30 am). They were allowed a light breakfast while still at home. The two bronchoprovocations were separated by an interval of 2–6 weeks, and the same protocol for allergen dose increments was used at both occasions. For each challenge, the starting allergen dose was selected ...
Version 7
... concentrations of unchanged buspirone are seen, with an increase in the half life time. In these patients buspirone should be used with caution and individual dosages should be titrated with care to reduce the chance of central undesirable effects, which may occur because of high maximum concentrati ...
... concentrations of unchanged buspirone are seen, with an increase in the half life time. In these patients buspirone should be used with caution and individual dosages should be titrated with care to reduce the chance of central undesirable effects, which may occur because of high maximum concentrati ...
Safe Handling of Hazardous Drugs
... This policy has been developed to promote safe work practices for all employees who prepare or administer hazardous drugs or clean up spills of these drugs. It is important to minimize occupational exposure to these drugs because of the risk of adverse health effects. This policy was originally base ...
... This policy has been developed to promote safe work practices for all employees who prepare or administer hazardous drugs or clean up spills of these drugs. It is important to minimize occupational exposure to these drugs because of the risk of adverse health effects. This policy was originally base ...
Frequently Asked Questions about Mifepristone
... H of the FDA regulations, which allows the FDA to establish a distribution system to assure safe use of certain drugs the agency has found to be effective. Subpart H was only invoked after the clinical trials had been concluded and an approvable letter had been issued. Where is mifepristone manufact ...
... H of the FDA regulations, which allows the FDA to establish a distribution system to assure safe use of certain drugs the agency has found to be effective. Subpart H was only invoked after the clinical trials had been concluded and an approvable letter had been issued. Where is mifepristone manufact ...
PHYSICOCHEMICAL PROPERTIES OF HESPERIDIN NANOCRYSTAL Research Article RACHMAT MAULUDIN
... reduction to nanometer range. The nanoparticles improve the in vivo performance of poorly soluble drugs thus leading to an increased surface area and increased dissolution velocity. According to Kelvin-Gibbs and Ostwald-Freundlich equation, a drug nanoparticles provides also enhancement drug solubil ...
... reduction to nanometer range. The nanoparticles improve the in vivo performance of poorly soluble drugs thus leading to an increased surface area and increased dissolution velocity. According to Kelvin-Gibbs and Ostwald-Freundlich equation, a drug nanoparticles provides also enhancement drug solubil ...
Anticoagulation in patients with impaired renal function and with
... The mean anti-FXa activity did not differ significantly between the patients who experienced clinically relevant bleeding and those who did not in both groups of patients (23). The study was terminated earlier due to a higher mortality rate of patients treated with tinzaparin without finding risk fa ...
... The mean anti-FXa activity did not differ significantly between the patients who experienced clinically relevant bleeding and those who did not in both groups of patients (23). The study was terminated earlier due to a higher mortality rate of patients treated with tinzaparin without finding risk fa ...
product monograph including patient
... Nitroglycerin overdose may result in severe hypotension, persistent throbbing headache, vertigo, palpitations, visual disturbances, flushing, and perspiring skin (later becoming cold and cyanotic), nausea and vomiting (possibly with colic and even bloody diarrhea), syncope (especially in the upright ...
... Nitroglycerin overdose may result in severe hypotension, persistent throbbing headache, vertigo, palpitations, visual disturbances, flushing, and perspiring skin (later becoming cold and cyanotic), nausea and vomiting (possibly with colic and even bloody diarrhea), syncope (especially in the upright ...
... hyperreactivity slowly over the following six weeks (table 1). Thus, steroid effects on airway hyperreactivity appeared to be time-dependant. Moreover, their study showed a decrease in peripheral eosinophils after eight weeks treatment, possibly reflecting a dampening of the well-known inflammatory ...
Clinical Update on Hyperkalemia: Diagnosis, Evaluation and
... Jain N, Kotla S, Little BB, et al. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol. 2012;109:1510-1513. Moranne O, Froissart M, Rossert J, et al; NephroTest Study Group. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20:16 ...
... Jain N, Kotla S, Little BB, et al. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol. 2012;109:1510-1513. Moranne O, Froissart M, Rossert J, et al; NephroTest Study Group. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20:16 ...
Enhancing Prescription Medicine Adherence: A National Action Plan August 2007
... devastated the lives of millions. This includes more than 300 new drugs, biologics and vaccines approved by the U.S. Food and Drug Administration (FDA) since 1993 to prevent and treat over 150 medical conditions.(1) ...
... devastated the lives of millions. This includes more than 300 new drugs, biologics and vaccines approved by the U.S. Food and Drug Administration (FDA) since 1993 to prevent and treat over 150 medical conditions.(1) ...
Pfizer Guitly of Violating California Unfair Competition Law
... At trial, plaintiffs presented the testimony of Dr. David Kessler, an expert on how the federal Food and Drug Administration (FDA) works and how a pharmaceutical company interacts with the FDA. Dr. Kessler holds both a medical and a law degree from Harvard University. Dr. Kessler served as the Commi ...
... At trial, plaintiffs presented the testimony of Dr. David Kessler, an expert on how the federal Food and Drug Administration (FDA) works and how a pharmaceutical company interacts with the FDA. Dr. Kessler holds both a medical and a law degree from Harvard University. Dr. Kessler served as the Commi ...
NIDA Research Report - MDMA
... Nevertheless, the drug gained a in Germany in the small following among psychiaearly 1900s as a parent trists in the late 1970s and early compound to be used to 1980s, with some even calling it synthesize other pharmaceuticals. “penicillin for the soul” because During the 1970s, in the United it was ...
... Nevertheless, the drug gained a in Germany in the small following among psychiaearly 1900s as a parent trists in the late 1970s and early compound to be used to 1980s, with some even calling it synthesize other pharmaceuticals. “penicillin for the soul” because During the 1970s, in the United it was ...
LSEHWP40
... treatment) of pregnant women suffering from RA; (c) to raise awareness among patients and healthcare professionals with regard to the potential risks of RA treatment in pregnancy for both mother and foetus; and (d) to explore the existence of guidelines for treating RA in pregnant women. Methodology ...
... treatment) of pregnant women suffering from RA; (c) to raise awareness among patients and healthcare professionals with regard to the potential risks of RA treatment in pregnancy for both mother and foetus; and (d) to explore the existence of guidelines for treating RA in pregnant women. Methodology ...
MSM (Methylsulfonylmethane)
... conducted to confirm these findings. Evidence: Barrager et al. conducted a multi-center, open label study in 55 patients with SAR receiving 2,600 mg MSM (OptiMSM® 650mg) for 30 days (1). By day 7, both upper and total respiratory symptoms significantly improved, and by day 14 energy levels increased ...
... conducted to confirm these findings. Evidence: Barrager et al. conducted a multi-center, open label study in 55 patients with SAR receiving 2,600 mg MSM (OptiMSM® 650mg) for 30 days (1). By day 7, both upper and total respiratory symptoms significantly improved, and by day 14 energy levels increased ...
Nasacort (triamcinolone acetonide)
... children or teenagers. Children should be maintained on the lowest dose which delivers adequate symptom control (see DOSAGE AND ADMINISTRATION section). A one-year double-blind, placebo-controlled parallel group study in 298 treated pediatric patients (3 to 9 years of age) was conducted to assess th ...
... children or teenagers. Children should be maintained on the lowest dose which delivers adequate symptom control (see DOSAGE AND ADMINISTRATION section). A one-year double-blind, placebo-controlled parallel group study in 298 treated pediatric patients (3 to 9 years of age) was conducted to assess th ...
Ganja and Geriatrics: The Health Benefits and Risks of Medicinal
... pill form is already available and approved by the FDA. However, this form of administration seems to be less popular in comparison to other forms of consumption. This could be partly because its euphoric effects are not immediate and cannot be reliably controlled, unlike the inhalation of smoke (Wi ...
... pill form is already available and approved by the FDA. However, this form of administration seems to be less popular in comparison to other forms of consumption. This could be partly because its euphoric effects are not immediate and cannot be reliably controlled, unlike the inhalation of smoke (Wi ...
Digoxin and mortality in atrial fibrillation: a prospective cohort study
... included after selection by a stepwise procedure using the Akaike information criteria (AIC) for inclusion/exclusion. All included variables and interactions are shown in Table 1. When analyzing possible sex-based differences, sex was excluded from the propensity score. The propensity score was then ...
... included after selection by a stepwise procedure using the Akaike information criteria (AIC) for inclusion/exclusion. All included variables and interactions are shown in Table 1. When analyzing possible sex-based differences, sex was excluded from the propensity score. The propensity score was then ...
the preparation and administration of blincyto ® brochure
... of each cycle, prior to a step dose (such as cycle 1 day 8), or when restarting an infusion after an interruption of 4 or more hours. Do not flush the BLINCYTO® infusion line, especially when changing infusion bags. Flushing when changing bags or at completion of infusion can result in excess dosage ...
... of each cycle, prior to a step dose (such as cycle 1 day 8), or when restarting an infusion after an interruption of 4 or more hours. Do not flush the BLINCYTO® infusion line, especially when changing infusion bags. Flushing when changing bags or at completion of infusion can result in excess dosage ...
guideline for the management of tricyclic antidepressant overdose
... reviews (Best Evidence Topic Summaries, BETs), the principles of which have been previously described26. Where relevant BETs had already been created, the search strategies were checked and updated when necessary. Having gathered and collated the evidence for each clinical question, the principle gu ...
... reviews (Best Evidence Topic Summaries, BETs), the principles of which have been previously described26. Where relevant BETs had already been created, the search strategies were checked and updated when necessary. Having gathered and collated the evidence for each clinical question, the principle gu ...
Saw Palmetto
... to begin within 30 days of treatment and to continue through at least 6 months, the longest period studied to date. There is a large placebo effect in studies in this field. Saw palmetto extracts do not significantly ...
... to begin within 30 days of treatment and to continue through at least 6 months, the longest period studied to date. There is a large placebo effect in studies in this field. Saw palmetto extracts do not significantly ...
Hormonal doping and androgenization of athletes
... officially banned by sports authorities, and their usage has been controlled through analysis of urine samples taken at the time of competition, i.e., after drug withdrawal, a rather inefficient and insensitive method. In addition, in many countries the use of such drugs in sports has been declared ...
... officially banned by sports authorities, and their usage has been controlled through analysis of urine samples taken at the time of competition, i.e., after drug withdrawal, a rather inefficient and insensitive method. In addition, in many countries the use of such drugs in sports has been declared ...
Training Manual for Physicians and Pharmacists on Medicinal drugs
... evaluation of the effectiveness of communicating DRUID results to drug consumers and young drivers (Germany), on the other hand. It was considered that there would be no significant additional gain in knowledge if the same types of studies would be conducted simultaneously in the four countries as i ...
... evaluation of the effectiveness of communicating DRUID results to drug consumers and young drivers (Germany), on the other hand. It was considered that there would be no significant additional gain in knowledge if the same types of studies would be conducted simultaneously in the four countries as i ...
Product Monograph
... cytochrome P450 3A (CYP3A) is not recommended as this may lead to significantly lower or higher exposure of simeprevir, respectively (see DRUG INTERACTIONS). Co-administration of amiodarone with GALEXOS® in combination with sofosbuvir is not recommended. Post-marketing cases of symptomatic bradycard ...
... cytochrome P450 3A (CYP3A) is not recommended as this may lead to significantly lower or higher exposure of simeprevir, respectively (see DRUG INTERACTIONS). Co-administration of amiodarone with GALEXOS® in combination with sofosbuvir is not recommended. Post-marketing cases of symptomatic bradycard ...
Full Prescribing Information for TOPAMAX® (topiramate)
... rate of the dialysis system being used, and 3) the effective renal clearance of topiramate in the ...
... rate of the dialysis system being used, and 3) the effective renal clearance of topiramate in the ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.